Gerresheimer AG (GXI.F)
| Previous Close | 101.20 |
| Open | 101.10 |
| Bid | 99.95 x 33200 |
| Ask | 100.10 x 33200 |
| Day's Range | 101.10 - 101.10 |
| 52 Week Range | 83.05 - 122.80 |
| Volume | |
| Avg. Volume | 177 |
| Market Cap | 3.499B |
| Beta (5Y Monthly) | 0.90 |
| PE Ratio (TTM) | 29.05 |
| EPS (TTM) | 3.48 |
| Earnings Date | Jul 11, 2024 |
| Forward Dividend & Yield | 1.25 (1.24%) |
| Ex-Dividend Date | Jun 06, 2024 |
| 1y Target Est | 131.10 |
Simply Wall St.Earnings Update: Gerresheimer AG (ETR:GXI) Just Reported Its First-Quarter Results And Analysts Are Updating Their Forecasts
Shareholders might have noticed that Gerresheimer AG ( ETR:GXI ) filed its quarterly result this time last week. The...
- Simply Wall St.
Gerresheimer (ETR:GXI) Is Paying Out A Dividend Of €1.25
Gerresheimer AG's ( ETR:GXI ) investors are due to receive a payment of €1.25 per share on 10th of June. Based on this...
ReutersGerresheimer shares down on outlook, but key contracts confirmed
The CEO of Germany's Gerresheimer confirmed on Thursday that the maker of packaging and medical equipment has contracts with leading players in the burgeoning weight-loss drugs sector, but its shares fell 4.4% after investors were underwhelmed by its second-quarter outlook. Though the company reiterated its core profit (adjusted EBITDA) forecast of 430 million to 450 million euros ($461.52 million to $482.99 million) for the year, CEO Dietmar Siemssen told analysts on a conference call that the ongoing reduction of inventory would weigh on the primary packaging glass division for the near future. First-quarter earnings at Gerresheimer's primary packaging glass division, which makes the vials, fell 14.5% versus last year to reach 34.8 million euros.
